Koios Care
Curated by SignalDeveloper of digital biomarkers and products to detect neurodegenrative diseases
Overview
Developer of digital biomarkers and products to detect neurodegenrative diseases. The company develops digital daily activity biomarkers to interface between providers and patients, with a focus on early detection and disease progression of parkinsons disease.
Key facts
- Founded
- 2022
- Headquarters
- Antwerp, Belgium
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view